Ovarian Cancer | Tumor

CURE’s ovarian cancer page is a go-to resource for oncology news and updates in the world of ovarian cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in ovarian cancer.

Jubilee Brown on Genetic Counseling for Patients With Breast and Ovarian Cancer

March 15th 2017, 6:41pm

Video

Jubilee Brown, M.D., obstetrician-gynecologist, Levine Cancer Institute, Carolinas HealthCare System, discusses genetic counseling for patients with breast and ovarian cancer.

PARP Inhibitors Are Changing the Treatment Landscape for Ovarian Cancer

March 15th 2017, 4:52pm

Article

PARP inhibitors like niraparib are bringing big change to the treatment of ovarian cancer, says Kathleen N. Moore, M.D.

Kathleen N. Moore Discusses New PARP Inhibitors for Ovarian Cancer

March 15th 2017, 12:37am

Video

Kathleen N. Moore, M.D., assistant professor, Stephenson Cancer Center, The University of Oklahoma, discusses developing new PARP inhibitors for patients with ovarian cancer. These new drugs may meaningfully prolong survival from a couple months to potentially years.

Niraparib Improves Progression-Free Survival in Ovarian Cancer, Regardless of BRCA Status

March 14th 2017, 10:32pm

Article

The PARP inhibitor niraparib proved to be effective in improving progression-free survival in recurrent ovarian cancer, according to a recent study.

Declining Concern about HPV Vaccine and Sexual Activity

March 13th 2017, 11:53pm

Article

Concern about vaccine safety and perceived lack of necessity remain the main reasons parents give for not having their teenage daughter vaccinated against HPV.

Genetic Counseling and Ovarian Cancer: 4 Questions With an Expert

March 13th 2017, 10:26pm

Article

Jubilee Brown, M.D., answers some common questions about genetic counseling in patients with ovarian cancer.

Ursula Matulonis Explains the Use of PARP Inhibitors for Ovarian Cancer

March 13th 2017, 9:31pm

Video

Ursula Matulonis, M.D., professor of Medicine, Harvard Medical School, Medical Director of Gynecologic Oncology, Dana-Farber Cancer Institute, explains the benefits of PARP inhibitors for patients with ovarian cancer.

Rucaparib Shows Promising Activity in Recurrent Ovarian Cancer

March 13th 2017, 8:59pm

Article

Elizabeth Swisher, M.D., discusses the ARIEL2 study, which proved that rucaparib may be a promising agent for patients with recurrent ovarian cancer.

Elizabeth Swisher Discusses Rucaparib's Side Effects for Patients With Ovarian Cancer

March 13th 2017, 1:12am

Video

Elizabeth Swisher, M.D., professor, Department of Medicine, Division of Medical Genetics, University of Washington School of Medicine, Breast and Ovarian Cancer Prevention Program, Seattle Cancer Care Alliance, discusses the side effects of rucaparib in the ARIEL2 trial, for patients with relapsed, platinum-sensitive high-grade ovarian carcinoma.

After Misdiagnosis, Patient Sees Promise With Immunotherapy Combination for Advanced Ovarian Cancer

March 10th 2017, 2:33am

Article

Marcia Goglia was given a laxative in the ER for what turned out to be ovarian cancer.